Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple
Clinical trial NCT02976272 · UNKNOWN
Trial details
- NCT number
- NCT02976272
- Sponsor
- University Hospital, Clermont-Ferrand
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2016-06-07
- Primary completion
- 2020-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.